3 results
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.
Approved WMOCompleted
Primary: To characterize the safety and tolerability of PDR001 in combination with LCL161, everolimus, HDM201, QBM076 or panobinostat and to identify recommended doses and schedules for future studies.Secondary: To characterize changes in the immune…